Literature DB >> 21953211

Cortical-limbic regions modulate depression and anxiety factors in functional dyspepsia: a PET-CT study.

Mai-Lan Liu1, Fan-Rong Liang, Fang Zeng, Yong Tang, Lei Lan, Wen-Zhong Song.   

Abstract

OBJECTIVE: To observe some specific brain areas or cerebral functional network participating in the modulation of depression and anxiety factors in functional dyspepsia (FD) patients by detecting cerebral glucose metabolism (CGM) in fluorine-18 fluorodeoxyglucose ((18)F-FDG) positron emission tomography-computed tomography (PET-CT) scans.
METHODS: Eight FD patients with depression and anxiety (DA-FD group) and eight FD patients without depression and anxiety (non-DA-FD group) were recruited and evaluated by the Nepean Dyspepsia Index (NDI) and Dyspepsia Symptom Scores (DSS). Cerebral (18)F-FDG PET-CT scans were performed on the DA-FD group and non-DA-FD group, respectively. The differences in CGM between the two groups were analyzed with SPM2.
RESULTS: Extensive changes in the CGM signals were observed in the cerebral cortex and limbic system of FD patients with depression and anxiety. Compared to non-DA-FD patients, DA-FD patients showed a higher glucose metabolism in the right postcentral gyrus (BA 1 and 5), inferior frontal gyrus (BA 45), superior temporal gyrus (BA 22), middle temporal gyrus (BA 22), inferior parietal lobule (BA 40), lingual gyrus (BA 18) and the left middle occipital gyrus (BA 37), as well as the limbic system including the left thalamus, lateral globus pallidus, parahippocampal gyrus (BA 35), right insular cortex (BA 13) and parahippocampal gyrus (BA 18); a lower glucose metabolism was presented in the left middle cingulated gyrus (BA 24), the right superior frontal gyrus (BA 6), the medial frontal gyrus (BA 6) and middle temporal gyrus (BA 21).
CONCLUSION: An extensive cortical-limbic brain network might modulate the procession of FD patients with depression and anxiety factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21953211     DOI: 10.1007/s12149-011-0537-4

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  6 in total

1.  Neural Responses of Acupuncture for Treating Functional Dyspepsia: An fMRI Study.

Authors:  Xiaohui Dong; Tao Yin; Siyi Yu; Zhaoxuan He; Yuan Chen; Peihong Ma; Yuzhu Qu; Shuai Yin; Xiaoyan Liu; Tingting Zhang; Liuyang Huang; Jin Lu; Qiyong Gong; Fang Zeng
Journal:  Front Neurosci       Date:  2022-05-02       Impact factor: 5.152

2.  The duration of acupuncture effects and its associated factors in chronic severe functional constipation: secondary analysis of a randomized controlled trial.

Authors:  Yang Wang; Yan Liu; Kehua Zhou; Brent A Bauer; Baoyan Liu; Tongsheng Su; Qian Mo; Zhishun Liu
Journal:  Therap Adv Gastroenterol       Date:  2019-10-09       Impact factor: 4.409

Review 3.  The role of psychosocial factors and psychiatric disorders in functional dyspepsia.

Authors:  Lukas Van Oudenhove; Qasim Aziz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

4.  Pimpinella anisum in the treatment of functional dyspepsia: A double-blind, randomized clinical trial.

Authors:  S Ashraffodin Ghoshegir; Mohammad Mazaheri; Alireza Ghannadi; Awat Feizi; Mahmoud Babaeian; Maryam Tanhaee; Mehrdad Karimi; Peyman Adibi
Journal:  J Res Med Sci       Date:  2015-01       Impact factor: 1.852

5.  Acute engagement of Gq-mediated signaling in the bed nucleus of the stria terminalis induces anxiety-like behavior.

Authors:  C M Mazzone; D Pati; M Michaelides; J DiBerto; J H Fox; G Tipton; C Anderson; K Duffy; J M McKlveen; J A Hardaway; S T Magness; W A Falls; S E Hammack; Z A McElligott; Y L Hurd; T L Kash
Journal:  Mol Psychiatry       Date:  2016-12-13       Impact factor: 15.992

6.  Assigning Clinical Significance and Symptom Severity Using the Zung Scales: Levels of Misclassification Arising from Confusion between Index and Raw Scores.

Authors:  Debra A Dunstan; Ned Scott
Journal:  Depress Res Treat       Date:  2018-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.